Loading...
Lupin Limited — Emtricitabine Export Profile: Buyers & Destinations
Loading...
Indian Pharmaceutical Exporter · #4 for Emtricitabine · $2.1M export value · DGFT Verified
Lupin Limited is the #4 Indian exporter of Emtricitabine with $2.1M in export value and 43 verified shipments. Lupin Limited holds a 1.8% market share in Emtricitabine exports across 4 countries. The company exports 38 pharmaceutical products worth $271.4M across 19 therapeutic categories.
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED KINGDOM | $928.0K | 19 | 52.2% |
| GERMANY | $417.3K | 12 | 23.5% |
| CZECH REPUBLIC | $381.7K | 11 | 21.5% |
| AUSTRALIA | $50.0K | 1 | 2.8% |
Lupin Limited exports Emtricitabine to 4 countries. The largest destination is UNITED KINGDOM accounting for 52.2% of Lupin Limited's Emtricitabine shipments, followed by GERMANY (23.5%) and CZECH REPUBLIC (21.5%). These destinations reflect Lupin Limited's established distribution network and regulatory approvals in key markets.
| Buyer | Country | Value | Orders |
|---|---|---|---|
| LUPIN HEALTHCARE (UK) LIMITED | UNITED KINGDOM | $828.0K | 17 |
| TRANS-O-FLEX LOGISTIK SERVICE GMBH | GERMANY | $341.8K | 10 |
| GLENMARK PHARMACEUTICALS S.R.O. | CZECH REPUBLIC | $183.3K | 5 |
| GLENMARK PHARMACEUTICALS S R O | CZECH REPUBLIC | $139.5K | 4 |
| LUPIN HEALTHCARE UK LIMITED | UNITED KINGDOM | $100.0K | 2 |
India exported $51.2M worth of Emtricitabine through 2,194 shipments from 141 suppliers to 117 countries, serving 493 buyers globally. Lupin Limited contributes $2.1M to this total, accounting for 1.8% of India's Emtricitabine exports. Lupin Limited ships Emtricitabine to 4 countries through 8 buyers.
Lupin Limited's average Emtricitabine shipment value is $50.0K per consignment, based on 43 shipments totaling $2.1M. The largest destination is UNITED KINGDOM (52.2% of Lupin Limited's Emtricitabine exports).
Lupin Limited ranks #4 among 141 Indian Emtricitabine exporters with a 1.8% market share. The top 3 exporters are MACLEODS PHARMACEUTICALS LTD ($14.0M), MYLAN LABORATORIES LIMITED ($13.3M), AUROBINDO PHARMA LTD ($5.9M). Lupin Limited processed 43 shipments to 4 destination countries.
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| EMTRICITABINE 200MG+TENOFOVIR DISOPROXIL | $633.8K | 17 |
| EMTRICITABINE 200MG+TENO PHO.245MG TABLETS UK(EMTRICITABINE 200MG+TENOFOVIR DISOPROXIL (AS PHOSPHATE) 245MG)-1BTLx30TABS | $200.0K | 4 |
| TENOFOVI P EMTRICIT 291 200MG TABS EMTRICITABINE200MG TENOFOVIR 291MG 1BTLx30T OTHERS MEDICINE PUT UP FOR RETAIL SALE | $50.0K | 1 |
| EMTRICITABINE 200MG TENOFOVIR DISOPROXIL245MG TABLETS GLEN DK SE 1BTLx30 TABS OTHERS MEDICINE PUT UP FOR RETAIL SALE | $50.0K | 1 |
| EMTRICITABINE 200MG+TENOFOVIR DISOPROXILAS PHOSPHATE 245MG TABLETS-1BTLx30TABSOTHER-MEDICINE PUT UP FOR RETAIL SALE | $50.0K | 1 |
| PHARMA : EMTRICITABINE 200MG + TENOFOVIR DISOPROXIL (AS PHOSPHATE) 245MG TABLETS UK - 1 BTL x 30TABS | $50.0K | 1 |
| EMTRI +TENO PHOS 200+245MG 30GLENMARK ESEMTRICITABINE AND TENOFOVIR DISOPROXIL(AS PHOSPHATE) TABLETS (QTY: 5,920 BT)NOS | $50.0K | 1 |
What Lupin Limited must comply with to export Emtricitabine to its top destination countries
Approval Process
Post-Brexit UK Marketing Authorisation via national procedure. Separate from EU approval since January 2021.
Timeline: 12–15 months
GMP & Export Requirements
UK GMP compliance; MHRA inspection of manufacturing site
Manufacturer Import Authorisation (MIA) held by UK importer; Qualified Person (QP) batch release
Note: Post-Brexit: EU GMP certificates no longer automatically valid in UK. Separate MHRA recognition required.
Approval Process
Marketing Authorisation via Decentralized or Mutual Recognition Procedure under EU Directive 2001/83/EC. CTD Module 1–5 dossier required.
Exporters ranked immediately above and below #4 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 6 | HETERO LABS LIMITED | $3.4M | 67 | 26 | $50.0K |
| 8 | AUROBINDO PHARMA LIMITED | $2.9M | 58 | 6 | $50.0K |
| 4 | LUPIN LIMITED ★ | $2.1M | 43 | 4 | $50.0K |
| 5 | CIPLA LIMITED | $2.0M | 40 | 10 | $50.0K |
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR CARGO ACC (INBOM4) | 524 | 23.9% |
| SAHAR AIR | 469 | 21.4% |
| Bombay Air | 166 | 7.6% |
| DELHI AIR | 153 | 7.0% |
| DELHI AIR CARGO ACC (INDEL4) | 141 | 6.4% |
| NHAVA SHEVA SEA (INNSA1) | 60 | 2.7% |
| Bombay Air Cargo | 55 | 2.5% |
| HYDERABAD ACC (INHYD4) | 54 | 2.5% |
Lupin Limited also exports these antiviral & hiv medications products. Each links to the detailed product page.
Lupin's export operations are influenced by various geopolitical factors. The ongoing Israel-Iran tensions have led to increased security risks in the Red Sea, prompting major shipping lines to implement 'Emergency Risk Surcharges' ranging from $250 to $500 per TEU, thereby escalating shipping costs for Indian exporters. (sgexports.odoo.com) Additionally, the 2025 United States–India diplomatic and trade crisis resulted in the U.S. imposing a 50% tariff on Indian exports, significantly affecting the competitiveness of Indian pharmaceutical products in the U.S. market. (en.wikipedia.org)
Conversely, the European Union's implementation of the Carbon Border Adjustment Mechanism (CBAM) poses compliance challenges for Indian exporters, including Lupin, necessitating adherence to stringent carbon reporting requirements. However, the EU's focus on reducing dependency on Chinese pharmaceutical imports presents an opportunity for Indian companies to capture a larger share of the European market.
Maintaining stringent quality standards is paramount for Lupin's global operations. In February 2025, the U.S. FDA completed a Pre-Approval Inspection at Lupin's Somerset, New Jersey facility with zero observations, reflecting the company's commitment to compliance and quality. (lupin.com) However, the evolving regulatory landscape, including the EU's falsified medicines directive and the U.S. FDA's increasing scrutiny, necessitates continuous investment in quality assurance and regulatory compliance to ensure uninterrupted market access.
Lupin Limited exports 38 products worth $271.4M. Beyond Emtricitabine, top products include Isoniazid, Cephalexin, Simvastatin, Rifampicin, Amlodipine. View the complete Lupin Limited profile for full portfolio analysis.
Latest developments and market context
Detailed market intelligence for Emtricitabine — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Lupin Limited's Emtricitabine exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Lupin Limited
Full Company Profile →
38 products · $271.4M total trade · 19 categories
| GERMANY |
| $75.5K |
| 2 |
| GLENMARK PHARMACEUTICALS, S.R.O | CZECH REPUBLIC | $59.0K | 2 |
| GENERIC HEALTH C O DHL SUPPLY CHAIN | AUSTRALIA | $50.0K | 1 |
Lupin Limited supplies Emtricitabine to 8 buyers globally. The largest buyer is LUPIN HEALTHCARE (UK) LIMITED (UNITED KINGDOM), followed by TRANS-O-FLEX LOGISTIK SERVICE GMBH (GERMANY) and GLENMARK PHARMACEUTICALS S.R.O. (CZECH REPUBLIC). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
| EMTRI+TENO PHOS 200+245MG 30 GLEN DK/SEEMTRICITABINE AND TENOFOVIR DISOPROXIL (AS PHOSPHATE) TABLETS (QTY: 16,480 BT)NOS | $50.0K | 1 |
| EMTR 200MG+TENO DIS.PH .245MG TABLETS HORMO (EMTRICITABINE 200MG+TENOFOVIR DISOPROXIL (AS PHOSPHATE) 245MG)-1BTLx90 TABS | $50.0K | 1 |
| EMTR 200MG+TENO DIS.PH.245MG TABLETS HORMO (EMTRICITABINE 200MG+TENOFOVIR DISOPROXIL (AS PHOSPHATE) 245MG)-1BTLx30 TABS | $50.0K | 1 |
Lupin Limited exports 24 distinct Emtricitabine formulations including tablets, capsules, syrups, and combination drugs. The top formulation is EMTRICITABINE 200MG+TENOFOVIR DISOPROXIL with 17 shipments worth $633.8K. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.
Timeline: 12–18 months via Decentralized Procedure
GMP & Export Requirements
EU GMP (EudraLex Vol. 4); GMP certificate from EU competent authority; WHO Prequalification accepted as supporting evidence
Certificate of Pharmaceutical Product (CPP) from CDSCO; Written Confirmation for API export per EU requirements; EU FMD serialization mandatory
Note: Indian manufacturers must hold EU GMP certificate. EU Falsified Medicines Directive (FMD) serialization and tamper-evident packaging mandatory.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
| 10 | EMCURE PHARMACEUTICALS LIMITED | $1.5M | 52 | 20 | $28.5K |
Lupin Limited ranks #4 among 141 Indian Emtricitabine exporters. Average shipment value of $50.0K compared to the market average of $363.2K. The closest competitors by value are HETERO LABS LIMITED and AUROBINDO PHARMA LIMITED.
Verify manufacturer licensing and export certifications with the official agencies above.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 117+ countries, 493+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Access shipment-level records, pricing trends, and buyer contacts for Lupin Limited.
Request DemoView Pricing →Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Emtricitabine. For current shipment-level data, contact TransData Nexus.